1696 – 1710 of 2187
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Polymorphisms in the IL-10 but not in the IL-1{beta} and IL-4 genes are associated with inhibitor development in patients with hemophilia A.
(
- Contribution to journal › Article
-
Mark
Kinin receptor expression during Staphylococcus aureus infection.
(
- Contribution to journal › Article
-
Mark
Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion
(
- Contribution to journal › Article
-
Mark
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A
(
- Contribution to journal › Article
-
Mark
Biosynthesis, processing, and sorting of human myeloperoxidase.
(
- Contribution to journal › Scientific review
-
Mark
Effective cell and gene therapy in a murine model of Gaucher disease.
(
- Contribution to journal › Article
-
Mark
Isolation and characterization of human myeloid progenitor populations--TpoR as discriminator between common myeloid and megakaryocyte/erythroid progenitors.
(
- Contribution to journal › Article
-
Mark
The cis-AB Blood Group Phenotype: Fundamental Lessons in Glycobiology.
(
- Contribution to journal › Scientific review
-
Mark
Weak D type 2 is the most prevalent weak D type in Portugal
(
- Contribution to journal › Article
-
Mark
Rabbit red blood cell stroma bind immunoglobulin M antibodies regardless of blood group specificity.
(
- Contribution to journal › Letter
-
Mark
Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest cell apoptosis and severe outflow tract defects
(
- Contribution to journal › Article
-
Mark
Identification of six new alleles at the FUT1 and FUT2 loci in ethnically diverse individuals with Bombay and Para-Bombay phenotypes.
(
- Contribution to journal › Article
-
Mark
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia
(
- Contribution to journal › Article
-
Mark
Talassemi i Sverige – Behandlingsmål och uppföljning varierar kraftigt.
(
- Contribution to journal › Article
-
Mark
Mechanisms for Targeting of Proteins to Secretory Lysosomes of Haematopoietic Cells
(
- Thesis › Doctoral thesis (compilation)